Grifols SA will collaborate with Chinese biotechnology company Boya Bio-pharmaceutical Group Co. Ltd. to build and manage plasma collection centers in the Asian country.
The collaboration will begin with an initial investment of €50 million.
Spain-based Grifols is a major world supplier of plasma-derived products.
